As of Apr 26, 2024, the PFE stock has a PE ratio of 66.84. The calculation is based on the latest EPS of $0.38 and the stock price of $25.4 per share. An increase of 140% has been observed in the PE ratio compared to its average of 27.8 of the last four quarters.
The mean historical PE ratio of Pfizer over the last ten years is 19.56. The current 66.84 P/E ratio is similar to the historical average. Looking back at the last ten years, PFE's PE ratio peaked in the Dec 2023 quarter at 75.76, with a price of $28.79 and an EPS of $0.38. The Apr 2023 quarter marked the lowest point at 7.89, with a price of $40.8 and an EPS of $5.17.
Maximum annual increase: 726.17% in 2023
Maximum annual decrease: -63.13% in 2017
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 75.76 | 726.17% |
| 2022 | 9.17 | -39.11% |
| 2021 | 15.06 | -32.5% |
| 2020 | 22.31 | 64.04% |
| 2019 | 13.6 | -40.79% |
| 2018 | 22.97 | 126.31% |
| 2017 | 10.15 | -63.13% |
| 2016 | 27.53 | -3.64% |
| 2015 | 28.57 | 32.09% |
| 2014 | 21.63 | 128.16% |
PFE's current PE ratio is higher than the 3, 5 and 10-year averages.
PFE's PE ratio stands lower than its peer stocks LLY and MRK, but it is higher than JNJ's and AZN's. Pfizer is currently trading at a higher PE ratio (66.84) than its peers average of 22.93.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 10.53 | $352.02B |
| NVS Novartis AG | 13.15 | $198.82B |
| AMGN Amgen Inc | 21.5 | $144.69B |
| ABT Abbott Laboratories | 32.78 | $186.58B |
| AZN Astrazeneca plc | 36.67 | $233.05B |
| PFE Pfizer Inc | 66.84 | $143.43B |
| LLY ELI LILLY & Co | 126.03 | $696.96B |
| MRK Merck & Co Inc | 937.14 | $332.28B |
| BMY Bristol Myers Squibb Co | N/A | $90.92B |
As of Apr 26, 2024, PFE stock has a price to earnings ratio of 66.84.
The average PE ratio for PFE stock over the past 3 years is 17.75.
The average PE ratio for PFE stock over the past 5 years is 17.46.
Over the last ten years, the quarterly PE ratio reached its highest level at 75.76 in the Dec 2023 quarter.
PFE's current price to earnings ratio is 242% above its 10-year historical average.
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Apr 26, 2024), Pfizer's share price is $25.4. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2023 is $0.38. Therefore, Pfizer's PE ratio for today is 66.84. PE RATIO(66.84) = STOCK PRICE($25.4) / TTM EPS($0.38)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.